CDMO — Avid Bioservices Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Avid Bioservices, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2020 April 30th	2021 April 30th	2022 April 30th	R2023 April 30th	2024 April 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-Q	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	36.3	170	126	38.5	38.1
Net Total Accounts Receivable
Net Total Receivables	11.9	25	25.9	27.9	29
Total Inventory
Prepaid Expenses
Total Current Assets	59.8	208	180	112	104
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	47.2	56.1	130	221	228
Other Long Term Assets
Total Assets	108	266	430	452	337
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	44.5	70.9	75.8	215	70.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	65.7	188	255	262	276
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	41.9	77.7	175	189	60.9
Total Liabilities & Shareholders' Equity	108	266	430	452	337
Total Common Shares Outstanding
Total Preferred Shares Outstanding